Drugs Made In America Acquisition (DMII) Cash from Operations (2025)
Drugs Made In America Acquisition (DMII) reported Cash from Operations of 314864.0 for Q4 2025.
Drugs Made In America Acquisition (DMII) has 1 years of Cash from Operations data on file, last reported at 314864.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | -121,028.00 |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - | -119,667.00 |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - | -72,157.00 |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - | -334,671.00 |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - | 1.32 Mn |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - | -207,911.00 |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - | -171,240.00 |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - | -227,953.00 |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - | -173,417.00 |
| 10 | Drugs Made In America Acquisition | 128.97 Mn | 128.97 Mn | - | -314,864.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -314,864.00 |
| Dec 31, 2025 | -314,864.00 |